<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
    	<title>IJPRS/V3/I3/00349 - 31/07/2014</title>

	<item>
		<title>Design, Development and In Vitro Evaluation of Controlled Release Microspheres of Losartan Potassium</title>
		
		<description><![CDATA[<h5>Author's Affiliation</h5>
		                                                <p></p>
		                                                <hr/>
                                                    	<h5>Abstract</h5>
		                                                <p>Microspheres are well accepted technique to control the drug release from the dosage form to improve bioavailability, reduce absorption difference in patients, reduce the dosing frequency and adverse effects during prolong treatment. The main objective of the present study is to prepare and evaluate Losartan potassium microspheres by Emulsification internal gelation method, with water soluble polymers such as Sodium alginate, Guar gum, Xanthan gum and Baco<sub>3 </sub>as crosslinking agent, using as carrier for oral administration in view to achieve oral controlled release of the drug. Losartan potassium is a Angiotensin II receptor blocker selectively and specifically antagonize the action of angiotensin II, a potent vasoconstrictor impacting BP regulation. Angiotensin II receptor blocker are becoming increasingly popular for the treatment of hypertension because they are effective and well tolerated. It has short biological half-life of 1.5-2 hrs. This necessitates multiple daily dosing for maintenance of its plasma concentration within the therapeutic index, hence there is impetus for developing controlled release dosage form that maintains therapeutic plasma drug concentration for long period. Compatibility studies revealed there was no interaction between the drug and polymers. The formulations were evaluated for particle size distribution analysis, flow properties like Angle of repose, bulk density, tapped density, Hausner’s Ratio, Carr’s index, microencapsulation efficiency, Scanning electron microscopy and <em>in-vitro</em> release studies. The optimized formulation showed good <em>in-vitro</em> controlled release activity of the drug Losartan potassium.</p>
                                                    	<hr/>
                                                        <h5>Keywords</h5>
                                                         <p>Controlled Release Microspheres, Sodium Alginate, Baco<sub>3</sub>, Cross Linking Agent, Emulsification Internal Gelation Method</p>
                                                         
                                                    	                                                    	<hr/>
                                                         <h5>Cite This Article</h5>
                                                         <p>Ramesh, B., Rao, L. R., Satyanandam, R., Sai, K. V., &amp; Martha, D. A. (2014). Design, Development and In Vitro Evaluation of Controlled Release Microspheres of Losartan Potassium. <em>International Journal for Pharmaceutical Research Scholars (IJPRS), 3(3),</em> 94-101.</p>                                                         <hr/>
                                                         <p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fdesign-development-and-in-vitro-evaluation-of-controlled-release-microspheres-of-losartan-potassium%2F&amp;linkname=Design%2C%20Development%20and%20In%20Vitro%20Evaluation%20of%20Controlled%20Release%20Microspheres%20of%20Losartan%20Potassium" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fdesign-development-and-in-vitro-evaluation-of-controlled-release-microspheres-of-losartan-potassium%2F&amp;linkname=Design%2C%20Development%20and%20In%20Vitro%20Evaluation%20of%20Controlled%20Release%20Microspheres%20of%20Losartan%20Potassium" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_dd addtoany_share_save addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fdesign-development-and-in-vitro-evaluation-of-controlled-release-microspheres-of-losartan-potassium%2F&#038;title=Design%2C%20Development%20and%20In%20Vitro%20Evaluation%20of%20Controlled%20Release%20Microspheres%20of%20Losartan%20Potassium" data-a2a-url="https://www.ijprs.com/article/design-development-and-in-vitro-evaluation-of-controlled-release-microspheres-of-losartan-potassium/" data-a2a-title="Design, Development and In Vitro Evaluation of Controlled Release Microspheres of Losartan Potassium"></a></p>]]>
        </description>
		<link>https://www.ijprs.com/article/design-development-and-in-vitro-evaluation-of-controlled-release-microspheres-of-losartan-potassium/</link>
		<author>Ramesh, B., Rao, L. R., Satyanandam, R., Sai, K. V., Martha, D. A.        </author>

		<pdflink>http://www.ijprs.com/wp-content/uploads/2018/09/IJPRS-V3-I3-00349.pdf</pdflink>

	</item>
</channel>
</rss>
